IRIS
AQUARO, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.442
AS - Asia 3.968
EU - Europa 2.844
SA - Sud America 1.239
AF - Africa 224
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 9
Totale 14.738
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.250
SG - Singapore 1.962
UA - Ucraina 1.248
BR - Brasile 1.010
CN - Cina 725
DE - Germania 677
VN - Vietnam 503
SE - Svezia 267
TR - Turchia 200
IT - Italia 162
HK - Hong Kong 160
KR - Corea 155
CA - Canada 150
SN - Senegal 110
AT - Austria 94
FR - Francia 90
AR - Argentina 82
FI - Finlandia 80
RU - Federazione Russa 68
EC - Ecuador 62
IN - India 57
BD - Bangladesh 48
ZA - Sudafrica 42
GB - Regno Unito 41
ID - Indonesia 29
MX - Messico 24
BE - Belgio 21
PY - Paraguay 20
CO - Colombia 19
PL - Polonia 19
IQ - Iraq 17
UZ - Uzbekistan 16
ES - Italia 14
MA - Marocco 14
VE - Venezuela 14
JP - Giappone 13
CL - Cile 12
KE - Kenya 12
UY - Uruguay 12
NL - Olanda 11
AL - Albania 10
EU - Europa 10
RO - Romania 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 6
AU - Australia 6
DZ - Algeria 6
EG - Egitto 6
ET - Etiopia 6
KZ - Kazakistan 6
PK - Pakistan 6
CZ - Repubblica Ceca 5
HN - Honduras 5
IL - Israele 5
LV - Lettonia 5
MY - Malesia 5
NP - Nepal 5
OM - Oman 5
SA - Arabia Saudita 5
BO - Bolivia 4
IE - Irlanda 4
JM - Giamaica 4
KG - Kirghizistan 4
PE - Perù 4
TZ - Tanzania 4
AZ - Azerbaigian 3
DK - Danimarca 3
GE - Georgia 3
GR - Grecia 3
IR - Iran 3
KW - Kuwait 3
LB - Libano 3
PA - Panama 3
QA - Qatar 3
AO - Angola 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CG - Congo 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GH - Ghana 1
GT - Guatemala 1
JO - Giordania 1
KH - Cambogia 1
LK - Sri Lanka 1
Totale 14.719
Salva come PNG Salva come JPEG
Città #
Dallas 1.450
Jacksonville 866
Chandler 607
Singapore 525
Dearborn 447
Boardman 432
San Mateo 341
Beijing 239
Ho Chi Minh City 210
Lawrence 186
Roxbury 182
Izmir 180
Seoul 155
New York 149
Hefei 142
Shanghai 129
Des Moines 118
Hanoi 113
Ottawa 113
Dakar 110
Ashburn 106
Hong Kong 92
São Paulo 90
Cambridge 83
Helsinki 71
Ann Arbor 66
Wilmington 65
Vienna 64
Brooklyn 57
Grafing 51
Ogden 47
Los Angeles 45
Rio de Janeiro 36
Inglewood 30
Rende 26
Seattle 25
Brasília 23
Guayaquil 23
Munich 22
Brussels 21
Haiphong 21
Quito 18
Rome 18
Salvador 18
Johannesburg 17
Toronto 17
Belo Horizonte 16
Ribeirão Preto 16
San Francisco 16
Guarulhos 15
Tashkent 15
Warsaw 15
Chicago 14
Council Bluffs 14
Moscow 14
Porto Alegre 14
Santa Clara 14
Strasbourg 14
Boston 13
Curitiba 13
Hải Dương 13
London 13
Biên Hòa 12
Da Nang 12
Tokyo 12
Asunción 11
Guangzhou 11
Nairobi 11
Phoenix 11
Amsterdam 10
Campinas 10
Montevideo 10
Norwalk 10
Wuhan 10
Charlotte 9
Columbus 9
Manaus 9
Ninh Bình 9
Pune 9
The Dalles 9
Thái Nguyên 9
Can Tho 8
Dhaka 8
Düsseldorf 8
Jiaxing 8
Nanjing 8
Turku 8
Betim 7
Bogotá 7
Bremen 7
Buenos Aires 7
Chennai 7
Florence 7
Fortaleza 7
Goiânia 7
Santo André 7
St Petersburg 7
São José dos Pinhais 7
Catanzaro 6
Caxias do Sul 6
Totale 8.405
Salva come PNG Salva come JPEG
Nome #
1,2,3-triazole-TSAO analogues: Synthesis and anti-HIV activity 1.460
Carbazole Derivatives as Antiviral Agents: An Overview 163
CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy 142
Identification of chlorocarbazole derivatives as potential antiviral agents. 128
Cachrys spp. from Southern Italy: Phytochemical Characterization and JAK/STAT Signaling Pathway Inhibition 126
Progettazione, studio di docking molecolare e sintesi di nuove molecole capaci di interagire con il virus responsabile della SARS-COVID 19. 125
Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs. 121
ANTIBACTERIAL AND ANTIVIRAL PHARMACEUTICAL COMPOSITION 121
Apoptosis in Human Astrocytic Cells Induced by HIV-Infected Macrophages 114
Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: new evidence and future perspectives 112
Antiretrovirus activity of novel class of acyclic pyrimidine nucleoside phosphonates 111
Chloro-1,4-dimethyl-9H-carbazole Derivatives Displaying Anti-HIV Activity 111
Activity of masked 2’-3’-dideoxynucleoside-monophosphate derivatives against human immunodeficiency virus in resting macrophages 109
Anti-HIV activity of protease inhibitors in productively-infected macrophages and correlation with clinical outcome 107
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics 106
Analisi mediante PCR dell’influenza di citochine sulla replicazione virale di HIV-1 e HSV-1 in macrofagi primari umani 105
Anti-nerve Growth Factor Antibody Abrogates Macrophages-mediated HIV-1 Infection and Depletion of CD4+ T-lymphocytes in hu-SCID Mice 105
Anti-HIV activity of nucleoside analogues in mononuclear cells. Workshop on Recent advances in modified nucleosides 105
Anti-HIV efficacy in primary monocyte/macrphage by phosphorylated and phosphonated derivatives of nucleside analogues 105
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies. 104
Activity of masked 2’-3’-Dideoxynucleoside Monophosphate Derivatives Against Human Immunodeficiency Virus in Resting Macrophages 103
Activity of GM-CSF and M-CSF upon Replication of HIV and Other DNA- and RNA-Viruses in Primary Macrophages 103
AZT treatment of HIV-1 infected macrophages prevents apoptosis and necrosis in human astrocytic cells 102
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90. 100
Anti-nerve growth factor Ab abrogates macrophage mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice 97
Antiviral activity of amprenavir in human macrophages acutely and chronically infected by HIV-1 92
Antiviral efficacy of inhibitors of HIV protease in chronically-infected macrophages 89
Acyclic nucleoside phosphonates: A new class of compounds with antiviral and immunomodulatory activity 89
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure 85
Activity of the (R)-Enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine [(R)-PMPA] and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine [(R)-PMPDAP] against Human Immunodeficiency Virus in Different Human Cell Systems 84
Thidiazuron: New Trends and Future Perspectives to Fight Xylella fastidiosa in Olive Trees 83
Factors affecting the anti-HIV and anti-HSV activity of nucleoside analogues in macrophages 81
CARBAZOLE DERIVATIVES TARGETING HUMAN TOPOISOMERASES I AND ACTIN IN BREAST CANCER TREATMENT 80
Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic. 79
Potent antiviral activity of amprenavir in primary macrophages infected by human immunodeficiency virus 79
Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir 78
Nerve growth factor in an autocrine factor essential for the survival of macrophages infected by human immunodeficiency virus 77
Modulazione dell’infezione da virus influenzale in macrofagi trattati con citochine 77
The counter-current centrifugal elutriation (cee) as essential tool for purification of monocytes and the assessment of the activity of cytokines upon virus replication 77
Understanding HIV compartments and reservoirs. 75
Studio di fattori che influenzano l’attivita’ anti-HIV ed anti-HSV di analoghi nucleosidici nei monociti-macrofagi 75
Il macrofago e l’infezione da HIV. Ruolo delle cellule lungo sopravviventi nella patogenesi e nella terapia. 75
Glutathione inhibits HIV replication by acting at late stages of virus lifecycle 75
Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically-infected macrophages 74
Effects of Amprenavir on HIV-1 Maturation, Production and Infectivity Following Drug Withdrawal in Chronically-Infected Monocytes/Macrophages 74
Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives 74
Does residual virus replication during successful HAART lead to HIV-1 genetic evolution? 73
Therapeutic strategies towards HIV-1 infection in macrophages 73
Antiviral activity of nucleoside analogues in macrophages 73
Cyclosaligenil-2’,3’-didehydro-2’,3’ – dideoxythymidine Monophosphate: efficient Intracellular Delivery of d4TMP 72
M40401, a sod mimetic compound with a potent anti-HIV activity in macrophages, prevents apoptosis in astrocytes 72
Attivita’ di farmaci inibitori del virus dell’immunodeficienza umana in macrofagi umani e correlazione con l’efficacia clinica 70
Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus 70
Microbiological Characteristics and Physico-chemical Parameters of Fermented Milk Product Ergo-A Traditional Yogurt Product of Ethiopia 70
The degree of HIV-1 amino acid variability is strictly related to different disease progression rates 70
Development of resistance to anti-HIV drugs in primary macrophages 70
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 69
Inhibition of HIV replication in primary macrophages by antiviral drugs: Modulation by cytokines and comparative efficacy in lymphocytes 69
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 69
Are Nutraceuticals Effective in COVID‐19 and Post‐COVID Prevention and Treatment? 68
Influenza virus A (H5N1): a pandemic risk? 68
Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus 68
Dinamica virale nei reservoirs. Infezioni da HIV: approfondimenti sul tema 67
Le mutazioni osservate nei macrofagi primari umani dopo trattamento con farmaci inibitori della transcrittasi inversa non conferiscono resistenza 67
The Ongoing Impact of COVID-19 on Pediatric Obesity 66
Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes 66
oxidative stress and HIV infection:target pathways for novel therapies? 66
The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages 66
The Potent Inhibition of Human Immunodeficiency Virus and Herpes Simplex Virus Type 1 by 9-(2-Phosphonylmethoxyethyl)Adenine (PMEA) in Primary Macrophages Is Determined by Drug Metabolism, Nucleotide Pools and Cytokines 66
In vitro activity of inhibitors of late stages of the replication of HIV in chronically-infected macrophages 65
Long lasting and efficient inhibition of HIV replicationn in Human primary macrophages by treatment with protease inhibitors 65
Phosphorylated and phosphonated derivatives of nucleoside analogues are more active against HIV in monocyte/macrophages than in lymphocytes 65
The Treatment with the Fusion Inhibitor Enfuvirtide Influences the Appearance of Mutations in the HIV-1 Regulatory Protein Rev 65
Le basi razionali della terapia di associazione nel trattamento dell’AIDS 64
Razionale della terapia dell’encefalopatia da HIV-1: inibizione della replicazione virale in macrofagi 64
NEUROAIDS: VIROLOGICAL ASPECTS OF HIV INFECTION 63
Antiviral Profile of HIV Inhibitors in Macrophages: Implications for Therapy 63
Macrofagi infettati da HIV provocano in vitro morte cellulare per apoptosi in cellule astrocitarie 63
Cytokines in HIV infection 63
Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype. 62
Attività anti-HIV di differenti classi di farmaci antivirali di interesse clinico: valutazione in vitro dell’efficacia in monociti/macrofagi primari e linfociti 62
Selective targeting of antiviral compounds to macrophages via red blood cells drug delivery 62
The contribution of peroxynitrite generation in HIV replication in human primary macrophages 62
S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation 62
Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029. 61
Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages 61
HIV-1-associated dementia during HAART therapy 61
Potente efficacia anti-HIV di LD 78 β isoforma di MIP-1α, in monociti e macrofagi umani 61
Factors released by HIV infected macrophages induce apoptosis of uninfected lymphocytes 61
TAK-779 blocca il corecettore CCR5 ed inibisce fortemente la replicazione di ceppi monocitotropi di HIV, in vitro ed in vivo 61
Silver and Gold Complexes with NHC-Ligands Derived from Caffeine: Catalytic and Pharmacological Activity 61
Identification of Pinosylvin in Pinus nigra subsp. laricio: A Naturally Occurring Stilbenoid Suppressing LPS-Induced Expression of Pro-Inflammatory Cytokines and Mediators and Inhibiting the JAK/STAT Signaling Pathway 60
NGF is an autocrine factor essential foe the survival of macrophages infected with HIV 60
Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist 60
Different antiviral activity of anti-HIV drugs in primary monocyte/macrophage cells and in lymphocytes: modulation by M-CSF 60
The Role of HIV Infection in Neurologic Injury. 60
HIV infection in macrophage: role of long-lived cells and related therapeutical strategies 60
Presence of 2’,5’-Bis-O-(tert-butyldimethilsylil)-3’-spiro-5”-(4”-amino-1”,2”-oxathiole-2”,2”-dioxide)(TSAO)-resistant virus strain in TSAO-inexperienced HIV patients 59
Phylogenetic analysis of the surface proteins of influenza A (H5N1) viruses isolated in Asian and African populations 59
Development of resistance to anti-HIV drugs in primary macrophages 59
Totale 9.359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.701
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021776 0 0 0 0 3 186 10 193 28 186 6 164
2021/20221.552 18 165 4 112 139 61 12 405 34 9 201 392
2022/20231.536 224 110 51 182 155 134 2 221 236 47 112 62
2023/2024881 88 25 56 27 46 172 21 35 107 30 46 228
2024/20252.365 139 456 51 92 129 106 74 132 435 136 202 413
2025/20265.010 1.166 577 1.606 1.150 511 0 0 0 0 0 0 0
Totale 14.826